{
    "organizations": [],
    "uuid": "7f17c28888bf17dba075ca2ef1ed39920e3fc4d7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-dova-pharmaceuticals-announces-app/brief-dova-pharmaceuticals-announces-appointment-of-mark-w-hahn-as-chief-financial-officer-idUSASB0C2XV",
    "ord_in_thread": 0,
    "title": "BRIEF-Dova Pharmaceuticals Announces Appointment Of Mark W. Hahn As Chief Financial Officer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Dova Pharmaceuticals Inc:\n* DOVA PHARMACEUTICALS ANNOUNCES THE APPOINTMENT OF MARK W. HAHN AS CHIEF FINANCIAL OFFICER\n* DOVA PHARMACEUTICALS INC - ‍DOUG BLANKENSHIP, DOVA‘S PREVIOUS CHIEF FINANCIAL OFFICER, HAS AGREED TO STEP DOWN​\n* DOVA PHARMACEUTICALS INC - MARK WILL OFFICIALLY COMMENCE IN HIS ROLE AS CHIEF FINANCIAL OFFICER OF DOVA ON JANUARY 31, 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-30T20:04:00.000+02:00",
    "crawled": "2018-01-31T16:49:11.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "dova",
        "pharmaceutical",
        "inc",
        "dova",
        "pharmaceutical",
        "announces",
        "appointment",
        "mark",
        "hahn",
        "chief",
        "financial",
        "officer",
        "dova",
        "pharmaceutical",
        "inc",
        "blankenship",
        "dova",
        "previous",
        "chief",
        "financial",
        "officer",
        "agreed",
        "step",
        "dova",
        "pharmaceutical",
        "inc",
        "mark",
        "officially",
        "commence",
        "role",
        "chief",
        "financial",
        "officer",
        "dova",
        "january",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}